IP's Developing Role In Cannabis Business Strategy
Rapidly growing interest in therapies and consumer products that include cannabis-derived compounds, including cannabidiol, recently spurred the U.S. Food and Drug Administration to hold its first public hearing on cannabis regulation...To view the full article, register now.
Already a subscriber? Click here to view full article